Skip to main content

Table 1 Clinicopathological parameters and the expression of miR-204-5p in NSCLC. Annotation: n number, SD standard deviation, NSCLC non-small cell lung cancer. a, paired sample’s t test performed to compare miR-204-5p expression between NSCLC and the controls; Independent sample’s t test processed to assess relationships between miR-30d-5p expression and the clinicopathological parameters of NSCLC. TNM, tumor, node, metastasis; b, One-way ANOVA preformed to evaluate distributive feature of miR-204-5p in three or more groups of clinicopathological parameters

From: Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses

Clinicopathological parameters

n

Relevant expression of miR-204-5p (2−ΔCq)

Mean ± SD

t/F-value

p-value

Tissue

NSCLC

125

3.6760 ± 1.87670

-3.507a

0.001

Non-cancer

125

4.6487 ± 2.46888

Gender

Male

75

4.0067 ± 1.91843

2.461

0.015

Female

50

3.1800 ± 1.71357

Age (years)

< 60

57

3.9526 ± 1.81847

1.517

0.132

> = 60

68

3.4441 ± 1.90650

Smoke

No

38

4.3368 ± 1.70205

−0.108

0.914

Yes

30

4.3833 ± 1.83041

Histological type

Adenocarcinoma

101

3.4663 ± 1.82397

−2.902

0.004

Squamous carcinoma

23

4.6870 ± 1.80638

Tumor size

<=3 cm

60

3.2417 ± 1.78547

−2.540

0.012

> 3 cm

65

4.0769 ± 1.88280

Vascular invasion

No

90

4.2233 ± 1.68876

5.898

< 0.001

Yes

35

2.2686 ± 1.59609

TNM

I-II

54

4.0870 ± 1.96383

2.167

0.032

III-IV

71

3.3634 ± 1.75770

Lymph node metastasis

No

56

4.2089 ± 1.95897

2.948

0.004

Yes

69

3.2435 ± 1.70142

Pathological grading

I

17

4.2176 ± 1.94140

2.797b

0.065

II

78

3.8090 ± 1.85404

III

30

3.6760 ± 1.87670